Literature DB >> 21150924

High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection.

Tomomitsu Miyagaki, Makoto Sugaya, Hitomi Yokobayashi, Toyoaki Kato, Hanako Ohmatsu, Hideki Fujita, Hidehisa Saeki, Yoshiki Kikuchi, Takeshi Tamaki, Shinichi Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21150924     DOI： 10.1038/jid.2010.366

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B.

Authors:  Juan Wang; Yanjun Cai; Huifan Ji; Junyan Feng; Desalegn Admassu Ayana; Junqi Niu; Yanfang Jiang
Journal:  J Interferon Cytokine Res       Date:  2012-02-03       Impact factor: 2.607

Review 2.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

3.  Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.

Authors:  Eric A Secemsky; Rebecca Scherzer; Elaine Nitta; Alan H B Wu; David C Lange; Steven G Deeks; Jeffrey N Martin; James Snider; Peter Ganz; Priscilla Y Hsue
Journal:  JACC Heart Fail       Date:  2015-07-08       Impact factor: 12.035

Review 4.  Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.

Authors:  Octavie Rostan; Muhammad Imran Arshad; Claire Piquet-Pellorce; Florence Robert-Gangneux; Jean-Pierre Gangneux; Michel Samson
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

Review 5.  IL-33 in Tumor Immunity: Nothing to Sneeze At.

Authors:  Donye Dominguez; Yi Zhang; Bin Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

6.  Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV.

Authors:  Christopher deFilippi; Robert Christenson; Jessica Joyce; Elli A Park; Ashley Wu; Kathleen V Fitch; Sara E Looby; Michael T Lu; Udo Hoffmann; Steven K Grinspoon; Janet Lo
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

7.  Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C.

Authors:  Juan Wang; Pingwei Zhao; Hui Guo; Xiguang Sun; Zhenyu Jiang; Lijun Xu; Junyan Feng; Junqi Niu; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2012-01-24       Impact factor: 4.711

8.  Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis.

Authors:  Muhammad Imran Arshad; Solène Patrat-Delon; Claire Piquet-Pellorce; Annie L'helgoualc'h; Michel Rauch; Valentine Genet; Catherine Lucas-Clerc; Christian Bleau; Lucie Lamontagne; Michel Samson
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

9.  Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.

Authors:  Ziying Lei; Zhishuo Mo; Jianyun Zhu; Xiuqing Pang; Xingrong Zheng; Zhebin Wu; Ke Wang; Xinhua Li; Dongying Xie; Zhiliang Gao
Journal:  Mediators Inflamm       Date:  2015-03-29       Impact factor: 4.711

10.  Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.

Authors:  Z Hladinova; Z Hruskova; B Svobodova; K Malickova; V Lanska; P Konopásek; E Jancova; R Rysava; C L Edelstein; V Tesar
Journal:  Mediators Inflamm       Date:  2015-02-23       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.